SyntheX
PrivateLast Round
Series A
Jan 11, 2024
Est. Valuation
$3.13M
Total Funding Raised
$18.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SyntheX is a biotechnology company that utilizes genetically engineered circuits and proprietary DNA-encoded libraries to discover novel therapeutics for cancer and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SyntheX Comparables
Compare SyntheX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proxygen | 87% | |
| Degron Therapeutics | 83% | |
| Bullseye Biosciences | 82% | |
SyntheX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 11, 2024 | ||||
| Debt | Apr 27, 2020 | ||||
| Seed | Apr 27, 2017 | ||||
| Seed | Feb 14, 2017 | ||||
| Accelerator | Jul 15, 2016 | ||||
Accelerator | Mar 1, 2016 |
SyntheX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morgan Noble Healthcare Partners | Series A |
| IndieBio | Seed, Accelerator |
| Oriza Ventures | Seed, Series A |
| OMX Ventures | Seed, Series A |
| 8VC | Seed, Series A |
| SOSV | Accelerator, Seed, Series A |
| SVB Financial Group | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 28, 2026
Grew 18% QoQ, from 34 to 40 employees.
SyntheX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SyntheX's valuation, stock price, and market status.